Literature DB >> 24037441

Cyclic AMP-dependent protein kinase enhances SC35-promoted Tau exon 10 inclusion.

Caoyi Chen1, Nana Jin, Wei Qian, Wen Liu, Xiangling Tan, Fei Ding, Xiaosong Gu, Khalid Iqbal, Cheng-Xin Gong, Ji Zuo, Fei Liu.   

Abstract

Alternative splicing of tau exon 10 generates tau with three or four microtubule-binding repeats (3R-tau or 4R-tau). The ratio of 3R-tau to 4R-tau is approximately 1:1 in the adult normal human brain. Disturbances in the ratio result in neurodegenerative tauopathies. Splicing factor SC35 acts on a SC35-like element located at the 5' end of tau exon 10 and promotes tau exon 10 inclusion. Here, we report that protein kinase (PKA) was able to interact and phosphorylate SC35. Activation or overexpression of PKA catalytic subunits promoted SC35-mediated tau exon 10 inclusion. Four PKA catalytic subunits, α1, α2, β1, and β2, all enhanced SC35-promoted tau exon 10 inclusion. SC35 has four putative PKA phosphorylation sites, Ser121, Ser128, Ser130, and Ser171. Pseudophosphorylation (SC354E) and blockage (SC354A) of phosphorylation of SC35 at these four sites increased and decreased, respectively, SC35's ability to promote tau exon 10 inclusion. Moreover, PKA catalytic subunits no longer further enhanced tau exon 10 inclusion when these four were mutated to either alanine or glutamate. These results suggest that PKA interacts with and phosphorylates SC35 and enhances SC35-promoted tau exon 10 inclusion. In Alzheimer's brain, down-regulation of the PKA pathway could lead to dysregulation of tau exon 10, contributing to tau pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037441     DOI: 10.1007/s12035-013-8542-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  39 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

Review 2.  Tau protein as a differential biomarker of tauopathies.

Authors:  Nicolas Sergeant; André Delacourte; Luc Buée
Journal:  Biochim Biophys Acta       Date:  2005-01-03

Review 3.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

4.  Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons.

Authors:  Sung-Wuk Jang; Xia Liu; Haian Fu; Howard Rees; Manuel Yepes; Allan Levey; Keqiang Ye
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

5.  PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners.

Authors:  Fei Liu; Zhihou Liang; Jianhua Shi; Dongmei Yin; Ezzat El-Akkad; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  FEBS Lett       Date:  2006-10-24       Impact factor: 4.124

6.  Paclitaxel C-10 carbamates: potential candidates for the treatment of neurodegenerative tauopathies.

Authors:  Carlo Ballatore; Edward Hyde; Robert F Deiches; Virginia M-Y Lee; John Q Trojanowski; Donna Huryn; Amos B Smith
Journal:  Bioorg Med Chem Lett       Date:  2007-04-25       Impact factor: 2.823

7.  Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain.

Authors:  Zhihou Liang; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2007-10-01       Impact factor: 5.372

8.  Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.

Authors:  F Rossi; E Labourier; T Forné; G Divita; J Derancourt; J F Riou; E Antoine; G Cathala; C Brunel; J Tazi
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  6 in total

Review 1.  Regulation of alternative splicing of tau exon 10.

Authors:  Wei Qian; Fei Liu
Journal:  Neurosci Bull       Date:  2014-03-14       Impact factor: 5.203

Review 2.  Splicing factor SRSF2-centric gene regulation.

Authors:  Kun Li; Ziqiang Wang
Journal:  Int J Biol Sci       Date:  2021-04-16       Impact factor: 6.580

Review 3.  Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review.

Authors:  Margaret F Keil; George Briassoulis; Constantine A Stratakis; T John Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-29       Impact factor: 5.555

4.  Alternative Splicing in Alzheimer's Disease.

Authors:  Julia E Love; Eric J Hayden; Troy T Rohn
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2015-08-15

Review 5.  Tau mis-splicing in the pathogenesis of neurodegenerative disorders.

Authors:  Sun Ah Park; Sang Il Ahn; Jean-Marc Gallo
Journal:  BMB Rep       Date:  2016-08       Impact factor: 4.778

6.  Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  J Exp Med       Date:  2018-10-29       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.